title: Cerebral tuberculoma with pulmonary tuberculosis in a patient with psoriasis treated with adalimumab, an anti-tumor necrosis factor-α agent.
authors.affiliation: Department of Dermatology, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.
authors.forename: Latha
authors.initials: L
authors.lastname: Selvarajah
authors.affiliation: Department of Dermatology, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia. choonse@yahoo.co.uk.
authors.forename: Siew Eng
authors.initials: SE
authors.lastname: Choon
authors.affiliation: Department of Respiratory Medicine, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.
authors.forename: Noor Aliza
authors.initials: NA
authors.lastname: Tarekh
authors.affiliation: Department of Pathology, Hospital Sultanah Aminah, Johor Bahru, Johor, Malaysia.
authors.forename: Arati D
authors.initials: AD
authors.lastname: Chhetri
mesh_terms: D000068879:Adalimumab / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D054022:Cerebrum; D006801:Humans; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000150:complications; D016862:Tuberculoma, Intracranial / Q000139:chemically induced* / Q000150:complications; D014397:Tuberculosis, Pulmonary / Q000139:chemically induced* / Q000150:complications; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab